Anticonvulsant medications for panic disorder: a review and synthesis of the evidence

References

• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th edition. Arlington, VA: APA.
   Google Scholar
• Baetz M, Bowen RC. 1998. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can J Psychiatry 43:73–77.
   PubMed Web of Science ®Google Scholar
• Boutros NN, Galloway MP, Ghosh S, Gjini K, Bowyer SM. 2013. Abnormal coherence imaging in panic disorder: a magnetoencephalography investigation. “http://www.ncbi.nlm.nih.gov.proxy.lib.wayne.edu/pubmed/23612562”. Neuroreport 24: 487–491.
   Google Scholar
• Boutros NN, Gjini K, Moran J, Chugani H, Bowyer S. 2013. Panic versus epilepsy: a challenging differential diagnosis. Clin EEG Neurosci 44:313–318.
   Google Scholar
• Clivaz E, Chauvert I, Zullino D, Niquille M, Maris S, Cicotti A, et al. 2008. Topiramate and panic attacks in patients with borderline personality disorder. Pharmacopsychiatry 41:79.
   Google Scholar
• Corrigan FM. 1992. Sodium valproate augmentation of fluoxetine or fluvoxamine effects. Biol Psychiatry 31:1178–1179.
   PubMed Web of Science ®Google Scholar
• Dantendorfer K, Frey F, Maierhofer D, Saletu B. 1996. Sudden arousal from slow wave sleep and panic disorder: successful treatment with anticonvulsants—a case report. Sleep 19:744–746.
   Google Scholar
• Damsa C, Warczyk S, Cailhol L, Kelley-Puskas AM, Cicotti A, Andreoli A. 2006. Panic attacks associated with topiramate. J Clin Psychiatry 67:326–327.
   Google Scholar
• Edlund MJ, Swann AC, Clothier J. 1987. Patients with panic attacks and abnormal EEG results. Am J Psychiatry 144:508–509.
   PubMed Web of Science ®Google Scholar
• Elisevich K, Shukla N, Moran JE, Smith B, Schultz L, Mason K, et al. 2011. An assessment of MEG coherence imaging in the study of temporal lobe epilepsy. Epilepsia 52:1110–1119.
   Google Scholar
• Gallinat J, Stotz-Ingenlath G, Lang UE, Hegerl U. 2003. Panic attacks, spike-wave activity, and limbic dysfunction. A case report. Pharmacopsychiatry 36:123–126.
   Google Scholar
• Goldberg JF. 2001. Panic attacks associated with use of topiramate. J Clin Psychopharmacol 21:461–462.
   PubMed Web of Science ®Google Scholar
• Goldensohn ES, Legatt AD, Koszer S, Wolf SM. 1999. Goldensohn's EEG interpretation: Problems of overreading and underreading. New York: Futura Publishing Company.
   Google Scholar
• Harvey BH. 1996. Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness. Hum Psychopharm 11: 309–319.
   Web of Science ®Google Scholar
• Harvey BH, Shahid M. 2012. Metabotrobic and ionotropic glutamate receptors as neurobiological targets in anxiety and stress-related disorders: focus on pharmacology and preclinical translational models. Pharmacol Biochem Behav 100:775–800.
   PubMed Web of Science ®Google Scholar
• Himmerich H, Nickel T, Dalal MA, Müller MB. 2007. Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal (Article in German). Psychiatr Prax 34:93–94.
   Google Scholar
• Hoffman EJ, Mathew JS. 2008. Anxiety disorders: a comprehensive review of pharmacotherapies. Mount Sinai J Med 75:248–262.
   PubMed Web of Science ®Google Scholar
• Huppertz HJ, Franck P, Korinthenberg R, Schulze-Bonhage A. 2002. Recurrent attacks of fear and visual hallucinations in a child. J Child Neurology 17:230–233.
   Google Scholar
• Keck PE Jr, Taylor VE, Tugrul KC, Bennett JA, Smith JM. 1993. Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 33:542–546.
   PubMedGoogle Scholar
• Lum M, Fontaine R, Elie R, Ontiveros A. 1990. Divalproex sodium's antipanic effect in panic disorder: a placebo-controlled study. Biol Psychiatry 27:164A–165A.
   Google Scholar
• Macrae D. 1954. On the nature of fear, with reference to its occurrence in epilepsy. J Nerv Ment Dis 120:385–393.
   Google Scholar
• Masdrakis VG, Papadimitriou GN, Oulis P. 2010. Lamotrigine administration in panic disorder with agoraphobia. Clin Neuropharmacol 33:126–128.
   Google Scholar
• Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL. 1989. Quality of life in panic disorder. Arch Gen Psychiatry 46: 984–992.
   PubMed Web of Science ®Google Scholar
• McNamara ME, Fogel BS. 1990. Anticonvulsant-responsive panic attacks with temporal lobe EEG abnormalities. J Neuropsychiatry Clin Neurosci 2:193–196.
   Google Scholar
• Nickell PV. 1994. Panic attacks, complex partial seizures, and multiple menengiomas. Anxiety 1:40–42.
   Google Scholar
• Ontiveros A, Fontaine R. 1992. Sodium valproate and clonazepam for treatment-resistant panic disorder. J Psychiatry Neurosci 17:78–80.
   Web of Science ®Google Scholar
• Pande AC, Pollack MH, Crockatt JM, Greiner M, Chouinard G, Lydiard RB, et al. 2000. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 20:467–471.
   PubMed Web of Science ®Google Scholar
• Pannekoek JN, Veer IM, van der Werff SJ, van der Werff SJ, Demenescu LR, Aleman A, et al. 2013. Aberrant limbic and salience resting-state functional connectivity in panic disorder without comorbidity. J Affect Disord 145:29–35.
   PubMed Web of Science ®Google Scholar
• Papp LA. 2006. Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study. J Clin Psychiatry 67:1573–1576.
   PubMed Web of Science ®Google Scholar
• Perugi G, Frare F, Toni C, Tusini G, Vannucchi G, Akiskal HS. 2010. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year “open” follow-up study. Eu Arch Psychiatry Clin Neurosci 260:553–560.
   PubMedGoogle Scholar
• Post RM, Weiss SRB, Pert A. 1996. Chronic cocaine administration sensitization and kindling effects. In: Uhlenhuth EH, Raskin A, Fisher S, editors. Cocaine: clinical and biobehavioral aspects. Oxford, England: Oxford University Press.
   Google Scholar
• Primeau F, Fontaine R, Beauclair L. 1990. Valproic acid and panic disorder. Can J Psychiatry 35:248–250.
   PubMed Web of Science ®Google Scholar
• Reid TL, Raj BA, Sheehan DR. 1988. Ictal panic/epiletptogenic activity: treatment with primidone. Psychosomatics 29:431–433.
   Google Scholar
• Roberts RJ, Gorman LL, Lee GP, Hines ME, Richardson ED, Riggle TA, Varney NR. 1992. The phenomenology of multiple partial seizure-like symptoms without stereotyped spells: an epilepsy spectrum disorder?Epilepsy Res 13:167–177.
   PubMed Web of Science ®Google Scholar
• Roy-Byrne PP, Ward NG, Donnelly PJ. 1989. Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry 50:44–48.
   PubMed Web of Science ®Google Scholar
• Schevon CA, Cappell J, Emerson R. 2007. Cortical abnormalities in epilepsy revealed by local EEG synchrony. NeuroImage 35: 140–148.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Sheehan KH, Raj BA, Janavs J. 2007. An open-label study of tiagabine in panic disorder. Psychopharmacol Bull 40:32–40.
   Google Scholar
• Slaap BR, den Boer JA. 2001. The prediction of non-response to pharmacotherapy in panic disorder; a review. Depress Anxiety 14:112–122.
   PubMed Web of Science ®Google Scholar
• Stein MB, Uhde TW. 1989. Infrequent occurence of EEG abnormalities in panic disorder. Am J Psychiatry 146:517–520.
   PubMed Web of Science ®Google Scholar
• Tondo L, Burrai C, Scamonatti L, Toccafondi F, Poddighe A, Minnai G, et al. 1989. Carbamazepine in panic disorder. Am J Psychiatry 164:4:558–559.
   Google Scholar
• Uhde TW, Stein MB, Post RM. 1989. Lack of efficacy of carbamazepine in the treatment of panic disorder. Am J Psychiatry 145:1104–1109.
   Google Scholar
• Weilburg JB, Schachter S, Sachs GS, Worth J, Pollack MH, Ives JR, Schomer DL. 1993. Focal paroxysmal EEG changes during atypical panic attacks. J Neuropsychiatry Clin Neurosci 5:50–55.
   PubMed Web of Science ®Google Scholar
• Windhaber J, Maierhofer D, Dantendorfer K. 1997. Oxcarbazepine for panic disorder occurring after two grand mal seizures: a case report. J Clin Psychiatry 58:404–405.
   Google Scholar
• Woodman CL, Noyes R Jr. 1994. Panic disorder: treatment with valproate. J Clin Psychiatry 55:134–136.
   Google Scholar
• Zwanzger P, Eser D, Nothdurfter C, Baghai TC, Möller HJ, Padberg F, Rupprecht R. 2009. Effect of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder. Pharmacopsychiatry 42:266–269.
   PubMed Web of Science ®Google Scholar